Harnessing LLM-Based AI Chatbots for Discovery and Preclinical Drug Discovery

Harnessing LLM-Based AI Chatbots for Discovery and Preclinical Drug Discovery

Introduction

For bioinformatics teams at life science companies, efficiently accessing and analyzing large-scale biological datasets is critical to driving discovery and preclinical research. However, navigating vast internal repositories—spanning genomic sequencing data, transcriptomic profiles, and experimental assay results—often requires complex queries and specialized expertise.

Large language models (LLMs) are transforming how bioinformatics teams interact with their data. By integrating artificial intelligence (AI) powered chatbots trained on domain-specific language, researchers can streamline data retrieval, uncover novel insights, and enhance predictive modeling—without the need for extensive coding or database management. These tools enable bioinformatics teams to extract meaningful patterns, cross-reference experimental results, and accelerate hypothesis generation in ways that were previously impractical.

This article explores how custom LLM-based AI chatbots empower bioinformatics teams to:

  • Conduct rapid, natural language queries across internal and public datasets
  • Automate complex bioinformatics workflows, including differential expression analysis and target identification
  • Integrate predictive modeling to assess drug efficacy, biomarker potential, and treatment response

Custom AI Chatbots allow for data accessibility

Traditional methods of data retrieval require complex searches across multiple databases, often necessitating expertise in structured query languages or proprietary software. Custom AI chatbots simplify this process by enabling natural language queries. Instead of sifting through endless documentation, researchers can now ask questions like:

“Tell me what we know about our internal asset, small molecule X?”

The chatbot parses internal datasets and provides precise, contextual answers, significantly reducing the time spent on manual searches.  Something like this prompt could return data about:

  • The effect of their molecule on differential gene expression compared to vehicle control
  • Links to all the internal studies on this molecule with summaries of their findings

But we can move beyond data retrieval and into predictive insights!

Beyond basic queries, a custom LLM can be designed to support predictive model building. Scientists often seek answers to complex questions such as:

  • “Would this small molecule have the potential to elicit expression of our main drug target?”
  • “Based on my previous assay data, at what dose would it be most effective?”
  • “Are there other drug treatment studies that have a similar signature of differential gene expression to my asset?”
  • “What are the top upregulated genes in immune cell cluster 4 from our single cell RNA-seq data after treatment with Compound X?”

The custom AI chatbot, fine-tuned with domain-specific language, is fast and efficient. It quickly accesses the curated single cell database and applies differential expression analysis to identify the most significantly upregulated genes within the specified immune cell cluster. Not only does it rank these gene products based on fold change and statistical significance, but it also cross-references corresponding bulk RNA-seq data to confirm these findings across larger tissue samples. If designed properly, the result is a comprehensive, data-driven report that pinpoints candidate biomarkers and potential therapeutic targets.

By integrating custom AI chatbots with advanced scientific models, including bioinformatic based queries, biotech firms can leverage their internal and open source repositories for hypothesis generation. The LLM doesn’t just retrieve information – it helps organize new insights based on existing experimental data, and historical research findings.

Customization for Biotech Companies

 Off-the-shelf AI solutions often fall short when it comes to industry-specific needs. Our approach focuses on:

1.       Secure Integration with Internal Data– We design AI with architectural modifications to ensure the highest standard of data privacy

2.    Domain-Specific Training – LLMs are fine-tuned on company-specific language, ensuring nuanced understanding of scientific terminology.

3.    Predictive Model Integration – We incorporate machine learning models that best answer the types of questions most relevant.  From small molecules, to genetic therapy, to biologics- the customization of your AI chatbot will be specific to the context of your data and therefore, the needs of your biological interests.

The Future of AI-Powered Drug Discovery

 AI will continue to reshape the biotech landscape.  The ability to query internal data and generate predictive insights will become a cornerstone of research and development. Custom AI chatbots are not just tools for retrieving information—they serve as digital research assistants, accelerating decision-making, enhancing innovation, and ultimately driving more effective drug discovery.

Outsourcing Bioinformatics Analysis: How Bridge Informatics (BI) Can Help

We are passionate about empowering life science companies with cutting-edge technologies. BI’s data scientists prioritize studying, understanding, and reporting on the latest developments so we can advise our clients confidently. Our bioinformaticians are trained bench biologists, so they understand the biological questions driving your computational analysis.

From pipeline development and software engineering to deploying your existing bioinformatic tools, BI can help you on every step of your research journey. As experts across data types from leading sequencing platforms, we can help you tackle the challenging computational tasks of storing, analyzing and interpreting genomic and transcriptomic data. Click here to schedule a free introductory call with a member of our team.

Share this article with a friend